Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced head and neck cancer
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference24 articles.
1. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: 3 meta-analyses of updated individual data. MACH-NC Collaborative Group Meta-Analysis of Chemotherapy on Head and Neck Cancer;Pignon;Lancet.,2000
2. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update;Pignon;Int J Radiat Oncol Biol Phys.,2007
3. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck;Budach;BMC Cancer.,2006
4. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy;Horiot;Radiother Oncol.,1992
5. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and 2 variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003;Fu;Int J Radiat Oncol Biol Phys.,2000
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of weekly versus triweekly cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma: A meta-analysis;Medicine;2022-12-30
2. Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate‐risk and high‐risk head and neck squamous cell carcinoma;Cancer;2021-08-11
3. Comparative study on hemato- and nephrotoxicity profile of weekly versus every 3-weekly cisplatin dosage during induction chemotherapy in locally advanced head neck squamous cell carcinoma;The Egyptian Journal of Otolaryngology;2021-07-28
4. Sinonasal Squamous Cell Carcinoma, a Narrative Reappraisal of the Current Evidence;Cancers;2021-06-07
5. Long-term Outcomes from Proton Therapy for Sinonasal Cancers;International Journal of Particle Therapy;2021-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3